Olatomide A. Fadare

420 citations

32 papers · 316 indexed · h-index 11

Co-authors: Deeksha Salaria Rajan Rolta Leila Tabrizi Lukman O. Olasunkanmi Craig A. Obafemi Jyoti Mehta Kayode Sanusi Banjo Semire
Topics: Computational Drug Discovery Methods (8 papers)Synthesis and biological activity (7 papers)Pharmacological Effects of Natural Compounds (5 papers)
Cited by: Drug Discovery Complementary and alternative medicine Toxicology
Journals: PLoS ONE Chemical Communications Scientific Reports
Partner nations: Nigeria India United States

In The Last Decade

Olatomide A. Fadare

29 papers receiving 310 citations

Peers

Countries citing papers authored by Olatomide A. Fadare

Since Specialization

Citations

This map shows the geographic impact of Olatomide A. Fadare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olatomide A. Fadare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olatomide A. Fadare more than expected).

Fields of papers citing papers by Olatomide A. Fadare

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olatomide A. Fadare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olatomide A. Fadare. The network helps show where Olatomide A. Fadare may publish in the future.

Co-authorship network of co-authors of Olatomide A. Fadare

This figure shows the co-authorship network connecting the top 25 collaborators of Olatomide A. Fadare. A scholar is included among the top collaborators of Olatomide A. Fadare based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olatomide A. Fadare. Olatomide A. Fadare is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Computational study of phytochemicals from Khaya grandifoliola (WELW) as potential inhibitors of the Plasmodium falciparum transketolase and putative antimalarial agents 2025 ·In Silico Pharmacology ·Joseph M. Agbedahunsi,(unknown),(unknown),(unknown),Deeksha Salaria,Rajan Rolta,(unknown),(unknown),(unknown),(unknown),Olatomide A. Fadare	0
2	Investigation of phytoconstituents interactions with human Src kinase in a bid to improve cholangiocarcinoma chemotherapy: An in-silico approach 2025 ·Biochemical and Biophysical Research Communications ·Rajan Rolta,Deeksha Salaria,Olatomide A. Fadare,Gurjeet Kaur,(unknown),Ajay Prakash,(unknown),Bikash Medhi	0
3	Evaluation of the pharmacological potential of Ganoderma lucidum against haemorrhagic and anticoagulant activities of Echis ocellatus venom 2025 ·BMC Biotechnology ·Omotayo Opemipo Oyedara,(unknown),(unknown),Olatomide A. Fadare,Olusanya Abiodun Olatunji,(unknown),(unknown),(unknown),(unknown),(unknown)	0
4	Identification of novel inhibitor phytoconstituents for Influenza A H3N2: an in silico approach 2024 ·Journal of Biomolecular Structure and Dynamics ·Rajan Rolta,Deeksha Salaria,Olatomide A. Fadare,(unknown),Gladson David Masih,Ajay Prakash,Bikash Medhi	5
5	In silico Investigation of the Antimalarial Activity of some Selected Alkaloids and Terpenoids Present in the Aerial Parts of Andrographis paniculata 2023 ·Tropical Journal of Natural Product Research ·(unknown),(unknown),Olatomide A. Fadare,(unknown)	1
6	Comparative docking studies of drugs and phytocompounds for emerging variants of SARS-CoV-2 2023 ·3 Biotech ·(unknown),(unknown),(unknown),(unknown),Rajan Rolta,(unknown),Deeksha Salaria,Olatomide A. Fadare,(unknown),(unknown),(unknown),Mansi Verma	17
7	Antibacterial Potential of Bacopa monnieri (L.) Wettst. and Its Bioactive Molecules against Uropathogens—An In Silico Study to Identify Potential Lead Molecule(s) for the Development of New Drugs to Treat Urinary Tract Infections 2022 ·Molecules ·Jyoti Mehta,(unknown),Shivkanya Fuloria,(unknown),Mahendran Sekar,Deeksha Salaria,Rajan Rolta,M. Yasmin Begum,Siew Hua Gan,Nur Najihah Izzati Mat Rani,Kumarappan Chidambaram,Vetriselvan Subramaniyan,Kathiresan V. Sathasivam,Pei Teng Lum,Subasini Uthirapathy,Olatomide A. Fadare,(unknown),Neeraj Kumar Fuloria	30
8	Synthesis and characterization of novel combretastatin analogues of 1,1-diaryl vinyl sulfones, with antiproliferative potential via in-silico and in-vitro studies 2022 ·Scientific Reports ·(unknown),Ahmed Kamal,(unknown),(unknown),Olatomide A. Fadare,(unknown),(unknown),Abimbola Peter Oluyori	7
9	Computational assessment of phytochemicals of medicinal plants from Mexico as potential inhibitors of Salmonella enterica efflux pump AcrB protein 2022 ·Journal of Biomolecular Structure and Dynamics ·Omotayo Opemipo Oyedara,Olatomide A. Fadare,(unknown),Norma Heredia,Santos García	11
10	Phytoconstituents of traditional Himalayan Herbs as potential inhibitors of Human Papillomavirus (HPV-18) for cervical cancer treatment: An In silico Approach 2022 ·PLoS ONE ·Deeksha Salaria,Rajan Rolta,Jyoti Mehta,(unknown),Olatomide A. Fadare,(unknown),Balvir Kumar,(unknown),(unknown),Neha Kaushik,Eun Ha Choi,Nagendra Kumar Kaushik	21
11	Structure based design, stability study and synthesis of the dinitrophenylhydrazone derivative of the oxidation product of lanosterol as a potential P. falciparum transketolase inhibitor and in-vivo antimalarial study 2021 ·In Silico Pharmacology ·Olatomide A. Fadare,Nusrat O. Omisore,(unknown),(unknown),(unknown),(unknown),Craig A. Obafemi	6
12	Computational screening of phytochemicals from three medicinal plants as inhibitors of transmembrane protease serine 2 implicated in SARS-CoV-2 infection 2021 ·Phytomedicine Plus ·Omotayo Opemipo Oyedara,Joseph M. Agbedahunsi,(unknown),(unknown),Olatomide A. Fadare,Charles Oluwaseun Adetunji,Gildardo Rivera	14
13	Biological Studies on Anthra[1,9-cd]pyrazol-6(2D)-one Analogues as Anti-vascular Endothelial Growth Factor Via In silico Mechanisms 2021 ·Chemistry Africa ·Abel Kolawole Oyebamiji,Olatomide A. Fadare,Sunday Adewale Akintelu,Banjo Semire	11
14	UHPLC/GC‐TOF‐MS metabolomics, MTT assay, and molecular docking studies reveal physostigmine as a new anticancer agent from the ethyl acetate and butanol fractions of Kigelia africana (Lam.) Benth. fruit extracts 2020 ·Biomedical Chromatography ·Oladapo F. Fagbohun,Babatunde Olawoye,Adedeji Nelson Ademakinwa,(unknown),(unknown),(unknown),Olatomide A. Fadare,Titus A.M. Msagati	9
15	Supramolecular architecture in 1:1 cocrystal of N-carbamothioylacetamide and N,N′-thiocarbonyldiacetamide from the attempted synthesis of 1,3-diacetyl-2-thioxoimidazolidine-4,5-dione (a thioparabanic acid derivative) 2020 ·Heliyon ·(unknown),Olatomide A. Fadare,Kayode Sanusi,(unknown),Ümit Ceylan,Craig A. Obafemi	2
16	Hybrid-based drug design of 1,2,3-triazole-pyrimidine-hybrid derivatives: Efficient inhibiting agents of mesenchymal–epithelial transition factor reducing gastric cancer cell growth 2020 ·Journal of Chemical Research ·Abel Kolawole Oyebamiji,Olatomide A. Fadare,Banjo Semire	8
17	De novodesign of thioredoxin reductase-targeted heterometallic titanocene–gold compounds of chlorambucil for mechanistic insights into renal cancer 2019 ·Chemical Communications ·Leila Tabrizi,Lukman O. Olasunkanmi,Olatomide A. Fadare	9
18	Molecular Docking and In-S ilico ADME Prediction of Substituted ( E )-4-Styryl-7,8-dihydroquinazolin-5(6 H )-ones and 5-(( E )-Styryl)pyrimidine[4,5-d]pyrimidine-2,4(1 H ,3 H )-diones as Potential SERT Inhibitors and Antidepressants 2018 ·(unknown),(unknown),(unknown),(unknown),Olatomide A. Fadare	3
19	In vitro antioxidant activity and gas chromatographymass spectrometry analysis of solvent extracts of Kigelia africana stem bark 2017 ·Journal of Pharmacy Research ·Craig A. Obafemi,Olatomide A. Fadare,(unknown),Efere M. Obuotor,(unknown),(unknown)	3
20	Synthesis, crystal structure and in vitro antibacterial activity of 2,3a,8b-trihydroxy-3-(thiophen-2-ylcarbonyl)-2-(trifluoromethyl)-2,3,3a,8b-tetrahydro-4H-indeno[1,2-b]furan-4-one 2013 ·Journal of Molecular Structure ·Craig A. Obafemi,Pius O. Adelani,Olatomide A. Fadare,David A. Akinpelu,(unknown)	7

About Olatomide A. Fadare

Olatomide A. Fadare is a scholar working on Pharmacology, Toxicology and Computational Theory and Mathematics, having authored 32 papers that have together received 316 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (8 papers), Synthesis and biological activity (7 papers) and Pharmacological Effects of Natural Compounds (5 papers). The work is most often cited by research in Drug Discovery (1 citation), Complementary and alternative medicine (36 citations) and Toxicology (15 citations). Olatomide A. Fadare has collaborated with scholars based in Nigeria, India and United States. Frequent co-authors include Deeksha Salaria, Rajan Rolta, Leila Tabrizi, Lukman O. Olasunkanmi, Craig A. Obafemi, Jyoti Mehta, Kayode Sanusi, Banjo Semire, Ümit Ceylan and Abel Kolawole Oyebamiji. Their work appears in journals such as PLoS ONE, Chemical Communications and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact